Core Framework & Diagram How Does Obesity Affect Immunity?
July 22, 20261 Min Read How Does Alcohol Affect Immunity?
July 22, 2026Fat isn't just excess storage — it's a continuously burning 'inflammation factory'
—— Why obesity makes vaccines ineffective, infections more lethal, and autoimmunity harder to control.
I. 'Crown-Like Structures' — the microscopic pathological starting point of adipose inflammation
Under the microscope, obese individuals' visceral adipose tissue has a unique pathological feature scientists gave a vivid name: Crown-Like Structures (CLS) — when hypertrophied adipocytes die, a ring of macrophages gather around them, forming a cell cluster resembling a crown. This CLS is the microscopic pathological starting point of local adipose tissue inflammation. The gathered macrophages, stimulated by the contents released from dying adipocytes (free fatty acids, damage-associated molecular patterns DAMPs), polarize into M1 type and begin continuously secreting large amounts of TNF-α, IL-1β, and IL-6. These inflammatory factors drain into systemic circulation through the portal vein, causing systemic chronic low-grade inflammation. Research finds that approximately fifty to seventy percent of adipocytes in obese individuals' visceral fat show CLS around them — not a minority of abnormal adipocytes, but over half of all adipocytes in a state of 'chronic death causing inflammation.' This is why waist circumference (proxy indicator of visceral fat) better predicts chronic inflammation levels and immune function than BMI (indicator of total weight).
2. Adiponectin decline — the immune regulation 'silencer' malfunctions
Adiponectin is an anti-inflammatory adipokine secreted by adipose tissue. Normal-weight individuals have plasma adiponectin concentrations approximately five to ten μg/mL; obese individuals typically have adiponectin concentrations dropping fifty to seventy percent, to two to five μg/mL — precisely when anti-inflammatory protection is most needed, this protective factor decreases. Adiponectin's immune functions: through AdipoR1/R2 receptors, activates AMPK pathway, inhibits NF-κB activation, reduces pro-inflammatory cytokine secretion; directly suppresses macrophage polarization toward M1 type; promotes DC tolerogenic development, reducing unnecessary immune activation; promotes NK cell differentiation toward 'regulatory NK cell' subsets. Adiponectin's persistently low levels mean all these 'anti-inflammatory-stabilizing' functions are continuously absent.
3. Obese individuals' vaccine protection is shorter — an underestimated public health problem
A 2012 study published in the International Journal of Obesity by Pamela Sheridan's team at the University of North Carolina had normal-weight and obese adults vaccinated with the same batch of influenza vaccine, then tracked antibody titers for twelve months. Result: at one month post-vaccination, both groups showed no significant antibody titer difference — the vaccine worked for both. But at twelve months, the proportion of the obese group maintaining protective antibody titers (≥40 HAI) was only approximately fifty percent of the normal-weight group.
In other words, the same vaccine, one year after administration, gave obese individuals approximately half the protective efficacy. For individuals, this means: if you have overweight/obesity, influenza vaccination remains necessary, but the protective duration may be shorter than normal-weight individuals — annual vaccination according to schedule is more important than 'vaccinated a few years ago, no need.'
4. 'Metabolic endotoxemia': the triangular link between obesity, gut microbiome, and chronic inflammation
In 2007, Patrice Cani's team at Ghent University Belgium published in Diabetes a study that made the entire field rethink 'how obesity triggers inflammation.' They found: high-fat-fed mice had plasma lipopolysaccharide (LPS, the main component of Gram-negative bacteria cell walls, one of the strongest known TLR4 activators) levels two to three times that of normally fed mice — even without any bacterial infection, blood plasma was full of bacterial fragments that should only exist in the intestine. They named this phenomenon 'Metabolic Endotoxemia.'
LPS enters blood through two pathways: high-fat diet chylomicrons (carrier particles transporting dietary fat) can 'carry along' LPS through the normal gut barrier during fat absorption; and high-fat low-fiber diet causes increased gut barrier permeability (leaky gut), with LPS entering the portal vein through the damaged gut barrier. LPS entering systemic circulation persistently activates the TLR4-NF-κB inflammatory pathway, producing pro-inflammatory cytokines like TNF-α and IL-6 — an 'endogenous inflammatory ignition' that doesn't depend on infection but is purely driven by diet and microbiome.
5. What weight loss changes — the different meanings of 5% and 10%
Weight loss's immune improvements occur in phases. Weight loss of five percent (through lifestyle intervention, approximately one to three months): adiponectin levels rise approximately thirty to fifty percent; CRP drops approximately fifteen to twenty-five percent; M1 macrophage proportion in adipose tissue begins declining, CLS density reduces. Weight loss of ten percent (typically requires three to six months of sustained intervention): NK cell activity and CTL function show measurable improvement; vaccine response efficacy partially recovers; plasma LBP (metabolic endotoxemia marker) significantly drops; gut microbiome diversity increases, butyrate-producing bacteria proportion rises.
Key insight: weight loss's immune improvements mainly come from visceral fat (abdominal obesity) reduction, not total body weight decrease. The combination of 'dietary control + aerobic exercise' (aerobic exercise is particularly effective at reducing visceral fat), in terms of inflammation improvement, outperforms diet restriction alone.
6. 'Normal weight obesity' — immune risk masked by BMI
One group whose obesity-related immune dysregulation is most easily missed: BMI normal (18.5–24.9) but waist circumference exceeds standards (males >90 cm, females >80 cm in Asian populations). This is called 'Normal Weight Obesity' (NWO) — weight looks normal, but visceral fat amount can be equivalent to overweight individuals. Multiple studies show NWO patients' CLS density and inflammatory marker levels are comparable to actually overweight individuals. For Asian populations especially: Asian people's visceral fat proportion is often higher than Westerners at the same BMI, meaning BMI 'within range' doesn't mean visceral fat is 'within range.' Periodically measuring waist circumference is a more important tool for assessing obesity immune risk than weighing on a scale.
7. Three things you can start today
First: measure waist circumference, not just weight. The scale won't tell you visceral fat amount, but a measuring tape will. If your waist circumference exceeds the standard, this is the most direct action signal — reducing visceral fat and lowering adipose tissue CLS density is a concrete goal with immune mechanism support, not the abstract goal of 'losing weight.'
Second: thirty minutes of aerobic exercise, today. No need to wait until 'lost five kilograms first' to feel improvement — after the first thirty minutes of exercise, NK cell numbers will briefly rise approximately forty to one hundred percent in blood. That's a change that can happen today. Aerobic exercise is particularly effective at reducing visceral fat, while muscle-sourced IL-6 triggers direct post-exercise anti-inflammatory effects.
Third: replace today's ultra-processed snack with one fermented food serving. A cup of plain unsweetened yogurt or a dish of kimchi isn't just supplementing probiotics — it's providing substrates for butyrate-producing bacteria, lowering LPS levels from metabolic endotoxemia, and improving the 'gut microbiome-leaky gut-LPS' pathway connecting obesity and chronic inflammation.
Frequently Asked Questions